Cargando…
How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
Drug resistance is an increasing problem for the treatment of tuberculosis. The prevalence of clinical isolates with pre-existing resistance needs to be considered in any drug discovery program. Non-specific mechanisms of resistance such as increased efflux or decreased permeability need to be consi...
Autores principales: | Bhagwat, Amala, Deshpande, Aditi, Parish, Tanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500310/ https://www.ncbi.nlm.nih.gov/pubmed/36159638 http://dx.doi.org/10.3389/fcimb.2022.974101 |
Ejemplares similares
-
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023) -
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023) -
Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023) -
Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022) -
The evolving biology of Mycobacterium tuberculosis drug resistance
por: Jones, Richard M., et al.
Publicado: (2022)